Auro-Silodosin · DIN 02478528 · 8 mg · capsule
Limited Use, Reason for Use code 351, 352 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 351, 352 required
Write on scriptone applicable Reason for Use code, 351 or 352 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 351, 352
Reason for Use code 351
For the management of benign prostatic hyperplasia where six weeks of treatment with other formulary alpha blockers (e.g. doxazosin, terazosin, tamsulosin) have been ineffective.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 352
For the management of benign prostatic hyperplasia where other formulary alpha blockers (e.g. doxazosin, terazosin, tamsulosin) have produced intolerable side effects.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Silodosin · DIN 02478528
Manufacturer: Auro Pharma Inc.; listing date 2022-04-29
Health Canada: Marketed since 2022-02-16 · brand AURO-SILODOSIN · ATC G04CA04 SILODOSIN · form Capsule · route Oral · ingredients SILODOSIN 8 MG · company Auro pharma inc · schedule Prescription
Auro-Silodosin: Formulary list price $0.47 per unit (the source does not state the unit; exact figure $0.4742). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02478528)
Source record
DIN 02478528: Auro-Silodosin
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 920000679; group id 961; item number 2282; lccId 00229; manufacturer id AUR
Source form: Cap; strength: 8mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4742; ministry $0.4742
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02478528
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96930
Interchangeable products
Jamp Silodosin · DIN 02539527 · $0.4742
PMS-Silodosin · DIN 02517787 · $0.4742
Rapaflo · DIN 02361671 · not recorded
Sandoz Silodosin · DIN 02475448 · $0.4742
Shortage status: not checked (no credentials)